High performance plasma amyloid-β biomarkers for Alzheimer’s disease

<p>Measurement of human plasma amyloid-β biomarkers using immunoprecipitation coupled with mass spectrometry reliably predicts individual brain amyloid-β status and has potential clinical utility.</p>